Dashboard
1
With a growth in Net Profit of 87.94%, the company declared Very Positive results in Sep 25
- The company has declared positive results in Jan 70 after 2 consecutive negative quarters
- OPERATING CASH FLOW(Y) Highest at CNY 450.87 MM
- RAW MATERIAL COST(Y) Fallen by -563.51% (YoY)
- DEBT-EQUITY RATIO (HY) Lowest at 86.56 %
2
With ROE of -44.88%, it has a risky valuation with a 2.83 Price to Book Value
3
Market Beating Performance
Stock DNA
Other Agricultural Products
CNY 2,214 Million (Small Cap)
NA (Loss Making)
NA
0.00%
0.85
-35.46%
1.52
Revenue and Profits:
Net Sales:
674 Million
(Quarterly Results - Mar 2026)
Net Profit:
176 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
23.64%
0%
23.64%
6 Months
6.76%
0%
6.76%
1 Year
43.07%
0%
43.07%
2 Years
98.97%
0%
98.97%
3 Years
0.65%
0%
0.65%
4 Years
27.51%
0%
27.51%
5 Years
-10.1%
0%
-10.1%
Shanghai Xuerong Biotechnology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-3.57%
EBIT Growth (5y)
-205.26%
EBIT to Interest (avg)
-2.40
Debt to EBITDA (avg)
44.06
Net Debt to Equity (avg)
1.44
Sales to Capital Employed (avg)
0.64
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.01%
ROE (avg)
1.48%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.83
EV to EBIT
-9.71
EV to EBITDA
-31.46
EV to Capital Employed
1.84
EV to Sales
2.76
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-18.96%
ROE (Latest)
-44.88%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
673.80
662.70
1.67%
Operating Profit (PBDIT) excl Other Income
188.50
189.00
-0.26%
Interest
9.40
16.00
-41.25%
Exceptional Items
0.00
0.00
Consolidate Net Profit
175.70
94.60
85.73%
Operating Profit Margin (Excl OI)
279.80%
161.00%
11.88%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 1.67% vs 25.25% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 85.73% vs 130.17% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,987.20
2,142.20
-7.24%
Operating Profit (PBDIT) excl Other Income
412.00
203.70
102.26%
Interest
61.30
98.90
-38.02%
Exceptional Items
0.30
-362.00
100.08%
Consolidate Net Profit
38.40
-616.40
106.23%
Operating Profit Margin (Excl OI)
36.00%
-81.90%
11.79%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -7.24% vs -15.81% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 106.23% vs -220.54% in Dec 2024
About Shanghai Xuerong Biotechnology Co., Ltd. 
Shanghai Xuerong Biotechnology Co., Ltd.
Other Agricultural Products
No Details Available.
Company Coordinates 
No Company Details Available






